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Abstract
Background: Nodular lymphoid hyperplasia of gastrointestinal tract is a rare disorder, often associated with
immunodeficiency syndromes. There are no published reports of its association with Helicobacter pylori infection.
Methods: From March 2005 till February 2010, we prospectively followed all patients with diffuse duodenal nodular
lymphoid hyperplasia (DDNLH). Patients underwent esophagogastroduodenoscopy with targeted biopsies,
colonoscopy, and small bowel video capsule endoscopy. Duodenal nodular lesions were graded from 0 to 4 based on
their size and density. Patients were screened for celiac sprue (IgA endomysial antibody), immunoglobulin abnormalities
(immunoglobulin levels & serum protein electrophoresis), small intestine bacterial overgrowth (lactulose hydrogen
breath test), and Helicobacter pylori infection (rapid urease test, and histological examination of gastric biopsies). Patients
infected with Helicobacter pylori received sequential antibiotic therapy and eradication of infection was evaluated by
14C
urea breath test. Follow up duodenoscopies with biopsies were performed to ascertain resolution of nodular lesions.
Results: Forty patients (Males 23, females 17; mean age ± 1SD 35.6 ± 14.6 years) with DDNLH were studied. Patients
presented with epigastric pain, vomiting, and weight loss. Esophagogastroduodenoscopy showed diffuse nodular
lesions (size varying from 2 to 5 mm or more) of varying grades (mean score ± 1SD 2.70 ± 0.84) involving postbulbar
duodenum. Video capsule endoscopies revealed nodular disease exclusively limited to duodenum. None of the
patients had immunoglobulin deficiency or small intestine bacterial overgrowth or positive IgA endomysial
antibodies. All patients were infected with Helicobacter pylori infection. Sequential antibiotic therapy eradicated
Helicobacter pylori infection in 26 patients. Follow up duodenoscopies in these patients showed significant reduction
of duodenal nodular lesions score (2.69 ± 0.79 to 1.50 ± 1.10; p < 0.001). Nodular lesions showed complete resolution
in 5 patients and significant resolution in remaining 21 patients. Patients with resistant Helicobacter pylori infection
showed no significant reduction of nodular lesions score (2.71 ± 0.96 to 2.64 ± 1.15; p = 0.58). Nodules partially
regressed in score in 2 patients, showed no interval change in 10 patients and progressed in 2 patients.
Conclusions: We report on a large cohort of patients with DDNLH, etiologically related to Helicobacter pylori
infection.
Background
Nodular lymphoid hyperplasia (NLH) of the gastrointest-
inal tract represents a rare disease that is grossly character-
ized by the presence of numerous visible mucosal nodules
measuring up to, and rarely exceeding, 0.5 cm in diameter
[1]. Histologically, hyperplasic lymphoid follicles with large
germinal centres are seen in the lamina propria and
superficial submucosa [2]. There is enlargement of the
mucosal B cell follicles caused by hyperplasia of the follicle
centres; surrounded by a normal appearing mantle zone.
Disease may involve the stomach, the entire small intestine,
and the large intestine [3]. NLH involving the colon can
mimic a variety of polyposis syndromes and this may cause
difficulties in diagnosis [4]. Disease has been reported to
cause pulmonary disease as well [5]. The etiology is
unknown. In children, NLH is often associated with viral
infection or food allergy; tends to have a benign course and
usually regresses spontaneously [6,7]. The disease in adults
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any medium, provided the original work is properly cited.is rare and poorly described [8]. It has been suggested that
NLH is a risk factor for both intestinal and extra intestinal
lymphoma [9-11]. Approximately 20% of adults with com-
m o nv a r i a b l ei m m u n o d e f i c i e n c ya r ef o u n dt oh a v eN L H
[12]. Some patients have low or absent IgA and IgM levels,
decreased IgG levels, susceptibility to infection, small intes-
tine bacterial overgrowth, diarrhea with or without steator-
rhea [13-16]. Giardia lamblia is often present in such
patients [17-19]. There is also an association with familial
adenomatous polyposis and Gardner’s syndrome [20]. It
has also been reported in patients with human immunode-
ficiency virus infection [21]. The disease may be associated
with other pathologies, especially gastrointestinal malig-
nancies [22]. Except an isolated case of gastric nodular
lymphoid hyperplasia, there are no published reports of
association of NLH with Helicobacter pylori (H. pylori)
infection [23]. Here, we report on a large cohort of patients
with NLH, etiologically related to H. pylori infection.
Methods
Study Protocol
From March 2005 till February 2010, we prospectively
followed all patients with diffuse duodenal nodular lym-
phoid hyperplasia (DDNLH). Patients had detailed his-
tory and physical examination. Complete blood counts
and serum chemistry were done by standard techniques.
Stool analysis was done for ova and parasites. Giardia
lamblia infection was evaluated by examinations of con-
centrated, iodine-stained wet stool preparations; duode-
nal aspirates and duodenal biopsies. IgA endomysial
antibodies were detected by indirect immunofluores-
cence assay. Serum immunoglobulin (IgG, IgA & IgM)
were estimated by immunoturbidometry. Serum protein
electrophoresis was performed by agarose gel electro-
phoresis and densitometry. Small intestine bacterial
overgrowth was evaluated by lactulose hydrogen breath
test. Patient underwent esophagogastroduodenoscopy
(EGD), targeted gastric and duodenal biopsies, evalua-
tion of H. pylori infection; colonoscopies with ileoscopy
and video capsule endoscopy. Patients infected with
H. pylori received 10 days sequential antibiotic therapy.
Eradication of H. pylori was evaluated by
14Cu r e a
breath Test (
14C UBT) 4 to 6 weeks after antibiotic ther-
apy. Patients resistant to sequential therapy received sec-
ond line antibiotic therapy. Follow up EGD’sw e r e
performed at/after 6 months of antibiotic therapy to
assess the status of the duodenal nodular lesions
detected earlier.
Diffuse Duodenal Nodular Lymphoid Hyperplasia
(DDNLH)
Nodular lymphoid hyperplasia was diagnosed when
numerous mucosal nodules (2 to 5 mm or more) were
visible on endoscopic examination of the gut mucosa
and histological examination of the forceps punch biop-
sies from nodules was reported as NLH [1]. NLH was
characterized by presence of well-circumscribed nodes
of lymphoid tissue in the lamina propria and/or superfi-
cial submucosa. These lymphoid collections showed pre-
sence of highly reactive germinal centres, numerous cell
types, prominent vascularity and polyclonality as deter-
mined immunohistochemically [2]. The extent of nodu-
lar lesions was evaluated by various imaging tools
including esophagogastroduodenoscopy, colonoscopy
with ileoscopy and video capsule endoscopy. Diffuse
nodular lesions limited to duodenum were diagnosed as
DDNLH.
Esophagogastroduodenoscopy (EGD)
EGD was performed by an experienced endoscopist
(MSK 3) with video-esophago-gastro-duodenoscope
(Olympus Evis Smartage Gastro GIF V70 Serial, Olympus
Japan). Procedures were video-recorded and representa-
tive findings documented on high resolution images
using software program. Endoscopic findings were
recorded on a proforma. Duodenum was carefully exam-
ined for nodules (circumscribed elevated mucosal lesions
varying in size from 2 mm to 5 mm or more). Nodular
lesions in the postbulbar duodenum, second and third
part were graded on a scale of 0 to 4, depending upon
t h es i z ea n dd e n s i t yo fn o d u l e s .G r a d i n gw a sd o n eb y2
investigators (MSK 3/NSK), blinded to results, by review-
ing EGD images and recorded video. Prior to actual grad-
ing, the scoring system was mutually agreed upon and
any discrepancies were mutually discussed and sorted
out. Normal duodenum (grade 0) showed prominent
smooth closely spaced Valvulae conniventes (Kerckring’s
folds) without scalloping or nodules. Nodules around 2 to
3 mm in size and less than 20 in number in the region
inspected were reported as grade1. Similar size numerous
(>20) nodules which had not deformed the duodenal
folds were reported as grade 2. Grade 3 nodular disease
was seen as numerous large (2 to 5 mm) nodules carpet-
ing the mucosa and causing mucosal fold invasion and
deformity. Nodules which were more than 5 mm in size
carpeting the whole duodenal mucosa and obscuring the
mucosal folds were reported as grade 4. Multiple (6 or
more) forceps biopsies were taken from nodules and the
intervening mucosa for histology. Biopsy specimens were
examined under light microscopy after staining with
hematoxylin and eosin; Periodic Acid Schiff (PAS) and
reticulin stains. Immunohistochemistry using CD3 &
CD20 markers was performed to evaluate the cell (T & B
cells) population in the lymphoid nodules. Biopsies were
examined for viral inclusions and parasites especially
Giardia lamblia [24]. H. pylori infection was evaluated
by rapid urease test (RUT) and at histology. For RUT, 2
forceps punch biopsies were taken from gastric incisura
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Allied Marketing Corporation, Kolkata, India) and read
as per manufacturer’s instructions. Multiple gastric biop-
sies (two from antrum; two from body and additional
specimens from any visible endoscopic visible lesions, if
needed) were taken and stained with Hematoxylin &
Eosin to type and grade gastritis; Alcian blue to detect
intestinal metaplasia and Giemsa stain for H. pylori
detection and density [25,26].
Colonoscopy
Colonoscopy with ileoscopy was performed by an
experienced endoscopist (MSK) with video-colonoscope
(Olympus Evis Smartage Colono CF V70L Serial,
Olympus Japan). Forceps biopsies were taken from
endoscopic abnormalities as well as terminal ileum.
Video Capsule Endoscopy
Small bowel video capsule endoscopy was performed on
capsule endoscopy system, Rapid 5 UPG with help of
Pillcam SB2 capsule (Given Imaging, Ltd. Israel). Video
images were examined for presence and extent of nodu-
lar lesions in the small bowel.
Lactulose Hydrogen Breath Test
Small intestinal bacterial overgrowth was evaluated by
analyzing breath hydrogen with Gastrolyzer (Bedfont
Scientific Ltd. Rochester, Kent, England) after a challenge
dose of lactulose (10 g) and breath samples collected at
baseline and subsequent 20 minutes intervals for 3 hours.
Positive diagnosis for small intestine bacterial overgrowth
was made if the breath hydrogen showed 20 ppm rise
above baseline within first 2 hours [27].
H. pylori Eradication
H. pylori eradication was done with sequential antibiotic
therapy. Patients received pantoprazole, 40 mg, with
amoxillin, 1 g, twice daily for 5 days followed by panto-
prazole, 40 mg, clarithromycin, 500 mg, and tinidazole,
500 mg, twice daily for next five days [28]. Following
sequential therapy, patients received symptomatic treat-
ment including pantoprazole 40 mg per day for next
4 weeks. Patients with resistant H. pylori infection to
sequential therapy received 10 days second line therapy
(pantoprazole 40 mg twice daily along with levofloxacin
750 mg and doxycycline 100 mg once daily). This anti-
biotic combination was based on H. pylori antibiotic
sensitivity in this region (Khuroo et al unpublished data).
14C Urea Breath Test (
14C UBT)
Eradication of H. pylori infection after antibiotic therapy
was evaluated by
14C UBT using Heliprobe™ System
2000 (Kibion AB, Uppsala, Sweden). After an overnight
fast, patient swallowed a
14C Urea Capsule (HeliCap™).
After 10 minute wait, patient breathed in to a breath
card (BreathCard™) till acid sensitive indicator changed
color from orange to yellow suggesting adequate trap-
ping of exhaled breath
14Carbon dioxide as lithium car-
bonate. Breath Card
14C activity was analyzed in a
Geiger Muller Counter (Probe™) and H. pylori infection
analyzed and presented on the display as Heliprobe
TM grade 0 (not infected), 1 (Indeterminate) and 2
(Infected).
Ethics
Written informed consent explaining the indications,
adverse affects and alternatives was obtained from all
patients before the procedures were carried out. The
study protocol was submitted to the ethical committee
of Digestive Diseases Centre and was approved. The
study protocol conformed to good medical practice as
defined in the Helsinki principles.
Statistics
Comparisons of the categorical variables were analyzed
using the Fisher’s exact test. Comparisons of the contin-
uous variables were analyzed using the Student’st - t e s t .
All values are expressed as mean ± SD and frequencies.
The statistical analysis was carried out using SPSS for
Windows (version 13.0). Two-tailed P values less than
0.05 were considered significant.
Results
From March 2005 till February 2010, 44 patients with NLH
of gastrointestinal tract were diagnosed. Two patients had
disease limited to distal ileum as visualized at colonoscopy
& ileoscopy. Another 2 patients had extensive disease
involving duodenum, jejunum and ileum. These 2 patients
had common variable immunodeficiency syndrome and
one of them presented with superadded recurrent Giardia
lamblia infection, Remaining 40p a t i e n t s( M a l e s2 3 ,
females 17; mean age ± 1SD 35.6 ± 14.6 years; age range
14 to 62 years) had diffuse nodular disease limited to duo-
denum and formed the study group (Table 1).
Dominant clinical presentation was epigastric pain, post-
prandial abdominal distension, vomiting and weight loss.
Duration of symptoms varied from 6 months to 5 years
(mean ± 1 SD 2.6 ± 1.2 years). Six patients presented with
recurrent episodes of diarrhoea, while 4 patients com-
plained of constipation. None of the patients had history
suggestive of steatorrhea. Hemoglobin ranged from 6 g/dl
to 12.5 g/dl (mean ± 1SD 9.5 ± 2.2 g/dl). Six patients had
severe anemia (<6.0 g/dl), 22 patients had moderate ane-
mia (6 to <8 g/dl) and 12 patients had mild anemia (8 to
<10 g/dl). Haematological indices revealed iron deficiency
anemia in all patients. None of the patients had megalo-
blastic anemia. Serum albumin ranged from 2.5 g/dl to
4.5 g/dl (mean ± 1SD 3.2 ± 1.1 g/dl). 8 patients had low
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in 10 patients. Immunoglobulin levels were within normal
limits in 26 patients. 14 patients had elevated immunoglo-
bulin levels (IgG in 6 patients, IgM in 5 patients, and IgA
in 3 patients). Elevated immunoglobulin levels were less
than 1.5 times of the upper limit of normal values. None
of the patients had low immunoglobulin level. Serum pro-
tein electrophoresis showed normal electrophoretic pat-
tern and none of the patients had M band pattern. None
of the patients had small intestine bacterial overgrowth as
assessed by lactulose hydrogen breath test. IgA endomysial
antibodies were negative in all patients. Stool analysis
revealed ova of Ascaris lumbricoides in 11 patients. All
patients with Ascaris lumbricoides infection received
anthelmintic therapy namely mebendazole 100 mg twice
daily per oral for 3 days. None of the patients had Giardia
lamblia infection as evaluated by examinations of concen-
trated, iodine-stained wet stool preparations; duodenal
aspirates and duodenal biopsies.
EGD showed diffuse nodular duodenal lesions in all
patients (Figure 1). Duodenal bulb showed smooth
mucosa, devoid of nodules in all patients. Nodular lesions
appeared just beyond the apex of the bulb and were
prominently seen in the second and third part of the duo-
denum. Nodular lesions were graded as grade 1 in
4 patients, grade 2 in 10 patients, grade 3 in 20 patients
and grade 4 in 6 patients (mean ± 1SD grade 2.7 ± 1.2).
All patients showed distensible duodenal lumen and none
Table 1 The clinical profile of 40 patients with diffuse duodenal nodular hyperplasia
Group All patients H pylori
eradicated
group
H pylori
persistent
group
P value
(Eradicated vs.
Non-eradicated)
Number of patients 40 26 14
Age (years ± 1SD) 35.6 ± 14.6 33.6 ± 11.6 37.6 ± 15.6 0.29c
Sex (Male: Female) 23:17 15:11 8:6 0.64a
Symptoms
(Number of patients)
Pain 40 26 14 1.00a
Vomiting 38 24 14 0.41a
Weight loss 35 23 12 0.77a
Diarrhoea 6 4 2 0.65a
Constipation 4 1 3 0.11a
Hemoglobin (g/dl) 9.5 ± 2.2 8.9 ± 3.2 9.7 ± 1.2 0.33c
Serum albumin (g/dl) 3.2 ± 1.1 3.4 ± 1.1 2.9 ± 1.4 0.39c
Immunoglobulins
(Number of patients)
Normal 26 18 8 0.14a
Elevated IgG 6 4 2 0.65a
Elevated IgM 5 4 1 0.41a
Elevated IgA 3 0 3 0.03a
Gastroscopic findings
(number of patients)
No abnormality 8 6 2 0.41a
Antral gastritis 20 11 9 0.16a
Fundic exudative gastritis 6 4 2 0.65a
Atrophic gastritis 4 3 1 0.56a
Ulcerative Nodular antral disease 2 2 0 0.41a
Grade of duodenal nodular disease
(Number of patients)
Grade 1 4 2 2 0.71b
Grade 2 10 7 3
Grade 3 20 14 6
Grade 4 6 3 3
Mean ± 1SD Score 2.70 ± 0.84 2.69 ± 0.79 2.71 ± 0.96 0.94c
Follow up months (mean ± 1SD) 24 ± 12.5 (6-56) 22 ± 14.5 (6-54) 26 ± 12.9 (8-56) 0.65c
a = Fisher’s exact test 2 × 2 table; b = Fisher’s exact test rxc table; c = students t test.
Key: The profile of 26 patients in whom H. pylori infection was eradicated and 14 patients in whom H. pylori infection was resistant to eradication therapy are
compared.
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tions. Examination of stomach showed no endoscopic
abnormality in 8 patients; linear erythematous antral gas-
tritis in 20 patients; exudative fundic gastritis in 6 patients
and atrophic gastritis in 4 patients. Two patients had dif-
fuse ulcerative nodular lesions limited to the antrum.
None of the patient had pyloric or duodenal ulcer. RUT
was positive in all patients and H. pylori were seen in gas-
tric biopsies in all patients. Density of H. pylori was mod-
erate in 6 patients and heavy in 34 patients. Histology of
gastric biopsies revealed chronic superficial gastritis in
24 patients, and chronic atrophic gastritis with intestinal
metaplasia in 14 patients. Two patients with diffuse ulcera-
tive nodular disease of antrum showed histologic features
of low grade MALT lymphoma. Duodenal biopsies
showed mature nodes of lymphoid follicles in lamina
propria (Figure 2). These lymphoid collections showed
presence of highly reactive germinal centres. In addi-
tion, lamina propria showed mild increase in lympho-
mononuclear cells. H. pylori were infrequently seen on the
duodenal mucosa and in small numbers. Duodenal biop-
sies lacked features of coeliac sprue namely blunted villi,
increased crypt depth, increased crypt villous ratio and
epithelial cell lymphocytosis. Immunohistochemistry
showed polyclonality of the cellular infiltrate which
excludes possibility of duodenal lymphoma. There were
no viral inclusions or Giardia lamblia seen in the tissue
specimens.
Video capsule endoscopy showed nodular lesions in
the postbulbar duodenum, second and third part of duo-
denum (Figure 3). There was marked reduction in the
Figure 1 Diffuse Duodenal Nodular Lymphoid Hyperplasia. 35 year male presented with epigastric pain, vomiting and weight loss of 5 kg
over the past 6 months. Duodenal composite images. Top left image: Duodenal bulb revealed smooth mucosa without any nodular lesion. Top
right and 2 bottom images: post-bulbar region, second and third part of duodenum showed diffuse numerous mucosal nodules (>5 mm size
each) scored as grade 4 disease. There was complete loss of Kerckring’s folds. Duodenal biopsies revealed nodular lymphoid hyperplasia.
Immunoglobulin revealed mild elevation of IgG level [IgG 2090 mg/dl (normal 700-1600 mg/dl); IgM. 120 mg/dl (normal = 40-230 mg/dl); IgA
145 mg/dl (normal = 70-400 mg/dl)].
Figure 2 Diffuse Duodenal Nodular Lymphoid Hyperplasia.
a) Low power view (H&E 10×) of duodenal biopsy showing a
lymphoid follicle. b) High power view (H&E 40×) A mature lymphoid
follicle with highly reactive germinal centre and surrounding normal
appearing mantle zone is seen. There is mild increase in lymphoid
infiltrate in the lamina propria.
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junction. There were no nodular lesions seen in the jeju-
num and ileum. Colonoscopy and ileoscopy was normal
in all cases and biopsies of the terminal ileum did not
reveal nodular lymphoid hyperplasia.
All patients received sequential antibiotic therapy. 14C
UBT, done 4 to 6 weeks following antibiotic therapy,
revealed eradication of H. pylori infection in 22 patients.
Another 4 patients had H. pylori eradication following
second line therapy. Remaining 14 patients had persistent
H. pylori infection. Abdominal pain and vomiting showed
improvement in 14 of the 26 patients in whom H pylori
had been eradicated (p < 0.001) (Table 2). In contrast
only 3 out of 14 patients with persistent H. pylori infec-
tion had improvement in symptoms (p = 0.22). Follow up
duodenoscopies in 26 patients with H. pylori eradicated
showed significant reduction of duodenal nodular lesions
score (2.69 ± 0.79 to 1.50 ± 1.10; p < 0.001). Nodular
lesions showed complete endoscopic and histological
resolution in 5 patients and significant resolution in
remaining 21 patients (Figure 4). Two patients with low
grade MALT lymphoma showed endoscopic and histolo-
gic resolution of the disease, after H. pylori eradication.
Patients with resistant H. pylori infection showed no sig-
nificant reduction of nodular lesions score (2.71 ± 0.96 to
2.64 ± 1.15; p = 0.58). Nodules regressed in 2 patients,
showed no interval change in 10 patients and progressed
in 2 patients (Figure 5). Histology of nodules which had
progressed over the follow up continued to show poly-
clonality and there was no suggestion of these nodules
evolving in to lymphoma.
Discussion
NLH of the gastrointestinal tract is a rare disorder, often
reported with immune deficiency disorders and/or
recurrent giardiasis [11-13,15,17-19]. The disease may
be localized to a segment or may affect longer segments
of bowel [13]. In contrast to reported disease in litera-
ture, the cohort of patients described in this study had
significant differences. Firstly the disease was often
Figure 3 Diffuse Duodenal Nodular Lymphoid Hyperplasia. Video Capsule Endoscopy composite images. Top 2 images: Second and third
part duodenum shows carpeting of the mucosa with nodular lesions. Bottom 2 images. Jejunum and ileum showed normal appearing mucosa
without any nodular lesions.
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5 years period is a testimony to that. Second the disease
involvement was limited to postbulbar duodenum,
second and third part and duodeno-jejunal junction.
Duodenal bulb was spared and there was no involvement
of jejunum and ileum. Third none of the patients
included in this study had immune deficiency or giardia-
sis. There are several reports of large cohort of patients
similar to described by us from Mexico [16,29]. However,
around half of such patients had hypogammaglobinemia.
Diarrhea and weight loss secondary to malabsorption
has been the dominant symptom of NLH of small bowel
as reported in the literature [1,15,30,31]. Malabsorption
is a common symptom in patients with immune defi-
ciency with or without superadded recurrent giardiasis
[32]. In contrast our patients with DDNLH presented
Table 2 The effects of H. pylori eradication therapy on 40 patients with diffuse duodenal nodular hyperplasia
Disease severity All patients
(n = 40)
Eradicated group
(n = 26)
Not eradicated group
(n = 14)
H. pylori
therapy
P value H. pylori
therapy
P value H. pylori
therapy
P value
Before After Before After Before After
Persistent symptoms 40 23 <0.001a 26 12 <0.001a 14 11 0.22a
Grade of nodular disease
Grade 0 0 5 0.005b 0 5 0.002b 0 0 0.91b
Grade 1 4 12 2 9 2 3
Grade 2 10 11 7 7 3 3
Grade 3 20 10 14 4 6 4
Grade 4 6 2 3 1 3 4
Mean ± 1SD Score 2.70 ± 0.84 1.83 ± 1.06 <0.001c 2.69 ± 0.79 1.50 ± 1.10 <0.001c 2.71 ± 0.96 2.64 ± 1.15 0.58c
a = Fisher’s exact test 2 × 2 table; b = Fisher’s exact test rxc table; c = students t test.
Figure 4 Diffuse Duodenal Nodular Lymphoid Hyperplasia. Duodenal composite images showing effect of H. pylori eradication. 25 year
woman presented with recurrent epigastric pain, vomiting and weight loss of 10 kg over past 2 years. Immunoglobulin levels were within
normal limits [IgG 1460 mg/dl (normal 700-1600 mg/dl); IgM. 190 mg/dl (normal = 40-230 mg/dl); IgA 230 mg/dl (normal = 70-400 mg/dl)].
Patient had H. pylori infection with severe fundic exudative gastritis. Top 2 images: Second part of duodenum was carpeted with numerous
nodular lesions 3 to 5 mm in size, scored as grade 3 nodular disease. Patient received H. pylori sequential therapy and
14C UBT 6 weeks after
therapy showed eradication of infection. Bottom 2 images. Follow up duodenoscopic images at one year showed near complete resolution of
the nodular lesions (scored as grade 0). Repeat duodenal biopsies failed to show nodular lymphoid follicles.
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gastric stasis and obstruction. Only 6 of our patients
presented with diarrhea which may suggest co-existent
malabsorption. Weight loss, gastric symptoms, iron lack
anemia, and hypoalbuminemia in our patients were
mostly caused by selective and dominant involvement of
the duodenal mucosa [31].
The pathogenesis of nodular lymphoid hyperplasia has
been a matter of debate for long. Histology of these lesions
demonstrates hyperplasic lymphoid follicles with mitotically
active germinal centres. In immune deficiency states, the
lymphoid hyperplasia is likely the result of an accumulation
of plasma-cell precursors due to maturational defect in the
development of B-lymphocytes [2,29]. These cells attempt
to compensate for functionally inadequate intestinal lym-
phoid function. Bacterial contamination of small intestines
is often mentioned as an etiological factor for NLH [16].
This is supported by regression of nodules following oral
antibiotic therapy in some cases [32]. Some investigators
suggest that coeliac disease may be associated with NLH
[1]. However, NLH may occur in a whole spectrum of dis-
orders without any abnormalities in immunoglobulins
[33-35]. It is believed that NLH in absence of immune defi-
ciency disorders may be related to immune stimulation of
the gut lymphoid tissue.
H. pylori infection is etiologically associated with a num-
ber of gastroduodenal disorders. Acute infection causes
neutrophilic gastritis with transient hypochlorhydria and
subjects complain of epigastric pain and nausea [36].
Chronic infection causes a wide variety of gastritis includ-
ing chronic superficial gastritis, nodular gastritis and
chronic atrophic corpus gastritis with metaplasia [37,38].
H. pylori infection is strongly associated with peptic
ulceration of duodenum and stomach [39,40]. Chronic
corpus atrophic gastritis with intestinal metaplasia caused
by H. pylori infection is an initiating event in most cases of
intestinal type adenocarcinomas stomach. In fact H. pylori
infection is associated with both diffuse-type and intest-
inal-type gastric adenocarcinoma [40,41]. Another entity
which is etiologically related to H. pylori infection is gas-
tric MALT lymphoma. The disease evolves through
H. Pylori gastritis with mucosa associated lymphoid tissue
(MALT), lymphoepithelial lesions, low grade B cell lym-
phoma and finally diffuse large B cell lymphoma [42-44].
Figure 5 Diffuse Duodenal Nodular Lymphoid Hyperplasia. Duodenal composite images. Progression of disease. 40 year women presented
with epigastric pain, vomiting, weight loss and recurrent diarrhoea. IgA levels were elevated [IgG 1400 mg/dl (normal 700-1600 mg/dl); IgM.
220 mg/dl (normal = 40-230 mg/dl); IgA 540 mg/dl (normal = 70-400 mg/dl)]. Patient had H. pylori related erythematous antral gastritis. Patient
received H. pylori eradication sequential therapy followed by Levofloxacin/Doxycycline based second line eradication therapy and
14C UBT
showed resistant H. pylori infection. Top 2 images. Duodenal mucosa showed diffuse infiltration with nodules of 3 to 5 mm size, scored as grade
3 nodular disease. Bottom 2 images at 2 years follow up. There was significant increase in size (>5 mm) and density of the nodular lesions.
Kerckring’s folds showed infiltration and focal thickening by nodular disease, scored as grade 4 nodular disease. Biopsies showed nodular
lymphoid follicles and infiltrate showed polyclonality of the lymphocytes.
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duodenal nodular lymphoid hyperplasia (DDNLH) with
H. pylori infection.
A number of findings strongly pointed to H. pylori to
be etiologically associated with DDNLH in our patients.
All patients were infected with H. pylori infection.
Patients in whom H. pylori were eradicated showed sig-
nificant clinical response and regression/resolution of
duodenal events. In contrast patients in whom H. pylori
could not be eradicated showed persistence of clinical
symptoms and persistence of duodenal nodular lesions.
A number of earlier studies have suggested H. pylori as
a possible cause of NLH [16,29], but none has followed
this lead and none has substantiated this association.
What could be the pathogenesis of DDNLH in our
patients? All patients had heavy H. pylori infection with
advanced changes in the stomach as evidenced by gastro-
scopic and histological findings. In fact 2 of our patients
had low grade MALT lymphoma. However, the duodenal
changes seen were not as a result of direct involvement by
H. pylori, as the organisms were not consistently present
in the duodenal biopsies. A number of nongastrointestinal
tract diseases are possibly associated with H. pylori infec-
tion. Many of these associations are suggested to be
related to the effects of H. pylori on coagulation and mar-
kers of systemic inflammation. We believe the duodenal
lesions were as a result of immune stimulation of pro-
longed and heavy H. pylori infection [45]. This was sup-
ported by elevated immunoglobulins in a number of
patients in our series. Some extragastric disease states are
particularly associated with H. pylori CagA-positive infec-
tions [46,47]. DDNLH seen in our community may be
related to high prevalence of such H. pylori infections in
our community and this need to be explored further. We
believe careful examination of post-bulbar and second part
of duodenum at EGD and liberal use of duodenal biopsies
in patients with heavy H. pylori infection in tropical coun-
tries is needed to define the impact of this disease.
Two of our patients who failed to eradicate H. pylori
infection had disease progression. However, biopsies
showed prominent lymphoid follicles with active germ-
inal centres located in the mucosa and there was no
suspicion of disease evolving in to lymphoma. NLH has
special relationship with lymphoma [7-9]. The disease
needs to be differentiated from lymphoma. The presence
of highly reactive germinal centres, numerous cell types,
prominent vascularity, and polyclonality as determined
immunohistochemically are the most important features
in the differential diagnosis with lymphoma. Lymphoid
hyperplasia may be differentiated from follicular lym-
phoma presenting as lymphomatous polyposis by Bcl-2
immunostaining of follicular germinal centres. NLH
may be a manifestation of extraintestinal lymphoma and
disease regresses after extraintestinal lymphoma
undergoes remission under chemotherapy [48]. May
patients with gastrointestinal lymphoma may present
with NLH. Moreover, studies have shown that NLH
itself may evolve in to lymphoma on long term follow
up. The study period in our patients was not enough to
define whether disease can evolve in to lymphoma. Long
term follow up of these patients needs to be done to
evaluate the malignant potential of this entity.
Conclusions
In summary, we report on 40 patients with DDNLH.
Patients presented with intractable dyspepsia and eso-
phagogastroduodenoscopy showed diffuse nodular
lesions of varying grades involving postbulbar duode-
num. None of the patients had immunoglobulin defi-
ciency or small intestine bacterial overgrowth or positive
IgA endomysial antibodies. All patients were infected
with H. pylori infection. Sequential antibiotic therapy
eradicated H. pylori infection in 26 patients. Follow up
duodenoscopies in these patients showed significant
reduction of duodenal nodular lesions score. Fourteen
patients with resistant H. pylori infection showed no sig-
nificant reduction of nodular lesions score. We believe
DDNLH in our patients was etiologically related to
H. pylori infection.
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